Deaths of individuals aged 16-24 years in the UK after using mephedrone

Human Psychopharmacology

Volumn 30, Issue 4, 2015, Pages 225-232

  Loi, Barbara ^a   Corkery, John Martin ^a   Claridge, Hugh ^a   Goodair, Christine ^a   Chiappini, Stefania ^a   Gimeno Clemente, Carla ^a   Schifano, Fabrizio ^b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

deaths; legal high; mephedrone; novel psychoactive substances; NPS; young people

Indexed keywords

4' METHYLMETHCATHINONE; CITALOPRAM; DIAZEPAM; METHAMPHETAMINE; STREET DRUG;

ADOLESCENT; ADULT; ALCOHOL CONSUMPTION; ARTICLE; BRONCHOPNEUMONIA; CAUCASIAN; CAUSE OF DEATH; DEPRESSION; DISSEMINATED INTRAVASCULAR CLOTTING; DROWNING; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG FATALITY; DRUG INTOXICATION; DRUG OVERDOSE; DRUG USE; EMPLOYMENT STATUS; ETHNICITY; HANGING; HUMAN; MOOD CHANGE; MULTIPLE DRUG ABUSE; MULTIPLE TRAUMA; PRIORITY JOURNAL; SEX DIFFERENCE; SUDDEN CARDIAC DEATH; SYSTEMATIC REVIEW; TIME OF DEATH; ANALOGS AND DERIVATIVES; BIBLIOGRAPHIC DATABASE; FEMALE; GREAT BRITAIN; MALE; MORTALITY; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

ADOLESCENT; DATABASES, BIBLIOGRAPHIC; FEMALE; GREAT BRITAIN; HUMANS; MALE; METHAMPHETAMINE; RETROSPECTIVE STUDIES; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84938063776     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2423     Document Type: Article

References (49)

1. Advisory Council on the Misuse of Drugs (ACMD). 2010. Advisory Council on the Misuse of Drugs on Consideration of the Cathinones. Home Office: London. Available at https://www.gov.uk/government/publications/acmd-report-on-the-consideration-of-the-cathinones (Accessed 7 March 2014)
2. Advisory Council on the Misuse of Drugs (ACMD). 2011. Consideration of the Novel Psychoactive Substances ('Legal Highs'). Home Office: London. Available at https://www.gov.uk/government/publications/novel-psychoactive-substances-report-2011 (Accessed 7 March 2014)
3. Carhart-Harris RL, King LA, Nutt DJ,. 2011. A Web-based survey on mephedrone. Drug Alcohol Depend 118: 19-22.
4. Corkery JM, Schifano F, Ghodse AH,. 2012. Mephedrone-related fatalities in the United Kingdom: contextual, clinical and practical issues. In Pharmacology, Gallelli L, (ed.). InTech: Rijeka, Croatia; 355-380. Available at http://www.intechopen.com/books/pharmacology/mephedrone-related-fatalities-in-the-united-kingdom-contextual-clinical-and-practical-issues (Accessed 7 March 2014)
5. Corkery J, Claridge H, Loi B, Goodair C, Schifano F,. 2014. Drug-related deaths in the UK: annual report 2013. Drug-related deaths reported by coroners in England, Wales, Northern Ireland, Guernsey, Jersey and the Isle of Man; police forces in Scotland; & the Northern Ireland Statistics and Research Agency-annual report January-December 2012. International Centre for Drug Policy: St George's University of London. Available at http://www.sgul.ac.uk/research/projects/icdp/our-work-programmes/pdfs/National%20Programme%20on%20Substance%20Abuse%20Deaths%20-%20Annual%20Report%202013%20on%20Drug-related%20Deaths%20in%20the%20UK%20January-December%202012%20PDF.pdf (Accessed 7 March 2014)
6. Cosbey SH, Peters KL, Quinn A, Bentley A,. 2013. Mephedrone (methylmethcathinone) in toxicology casework: a Northern Ireland perspective. J Anal Toxicol 37: 74-82.
7. Council of the European Union. 2011. Council conclusions on new psychoactive substances. Available at http://www.consilium.europa.eu/uedocs/cms-data/docs/pressdata/en/jha/126879.pdf (Accessed 3 June 2014)
8. Cozzi NV, Sievert MK, Shulgin AT, Jacob P, 3rd, Ruoho AE,. 1999. Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines. Eur J Pharmacol 381: 63-69.
9. Dargan PI, Sedefov R, Gallegos A, Wood DM,. 2011. The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone). Drug Test Anal 3: 454-463.
10. De Letter EA, Piette MH, Lambert WE, Cordonnier JA,. 2006. Amphetamines as potential inducers of fatalities: a review in the district of Ghent from 1976 to 2004. Med Sci Law 46: 37-65.
11. Dickson AJ, Vorce SP, Levine B, Past MR,. 2010. Multiple drug toxicity caused by the co-administration of 4-methylmethcatinone (mephedrone) and heroin. J Anal Toxicol 34: 162-168.
12. Durham M,. 2011. Ivory wave: the next mephedrone? Emerg Med J 28: 1059-1060.
13. Dyer C,. 2010. Mephedrone is an amphetamine "by another name" drug adviser tells MPs. BMJ 340: c1690.
14. EMCDDA. 2011. Report on the risk assessment of mephedrone in the framework of the Council Decision on new psychoactive substances, May 2011, European Monitoring Centre for Drugs and Drug Addiction: Lisbon. Available at http://www.emcdda.europa.eu/attachements.cfm/att-116646-EN-TDAK11001ENC-WEB-OPTIMISED%20FILE.pdf (Accessed 7 March 2014)
15. Europol-EMCDDA. 2010. Europol-EMCDDA Joint Report on a new psychoactive substance: 4-methylmethcathinone (mephedrone), March 2010, European Monitoring Centre for Drugs and Drug Addiction: Lisbon. Available at http://www.emcdda.europa.eu/attachements.cfm/att-132203-EN-2010-Mephedrone-Joint%20report.pdf (Accessed 7 March 2014)
16. Ghodse H, Corkery J, Ahmed K, Naidoo V, Oyefeso A, Schifano F,. 2010. Drug-related deaths in the UK: annual report 2010. Drug-related deaths reported by coroners in England, Wales, Northern Ireland, Guernsey, Jersey and the Isle of Man; police forces in Scotland; & the Northern Ireland Statistics and Research Agency-annual report January-December 2009. London: International Centre for Drug Policy: St George's University of London. 24 August 2010. Available at http://www.sgul.ac.uk/research/projects/icdp/pdf/np-SAD%2011th%20annual%20report%20Final.pdf (Accessed 10 March 2014)
17. Ghodse H, Corkery J, Claridge H, Goodair C, Schifano F.; 2013. Drug-related deaths in the UK: Annual Report 2012. Drug-related deaths reported by Coroners in England, Wales, Northern Ireland, Guernsey, Jersey and the Isle of Man; Police forces in Scotland; & the Northern Ireland Statistics and Research Agency-Annual Report January-December 2011. London: International Centre for Drug Policy: St George's University of London. 2013. Available at http://www.sgul.ac.uk/research/projects/icdp/our-work-programmes/substance-abuse-deaths (Accessed 10 March 2014)
18. Home Office. 2013. Drug Misuse: Findings from the 2012 to 2013 Crime Survey for England and Wales. Home Office: London. Available at https://www.gov.uk/government/publications/drug-misuse-findings-from-the-2012-to-2013-csew (Accessed 7 March 2014)
19. James D, Adams RD, Spears R, et al,. 2011. Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service. Emerg Med J 28: 686-689.
20. Kalix P,. 1990. Pharmacological properties of the stimulant khat. Pharmacol Ther 48: 397-416.
21. Kalix P,. 1992. Cathinone, a natural amphetamine. Pharmacol Toxicol 70: 77-86.
22. Lõpez-Arnau R, Martínez-Clemente J, Pubill D, Escubedo E, Camarasa J,. 2012. Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone. Br J Pharmacol 167: 407-420.
23. Maskell PD, DePaolie G, Seneviratne C, Pounder DJ,. 2011. Mephedrone (4-methylmethcathinone)-related deaths. J Anal Toxicol 35: 188-191.
24. Measham F, Moore K, Newcombe R, Welch Z,. 2010. Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition. Drugs Alcohol Today 10: 14-21.
25. Meltzer PC, Butler D, Deschamps JR, Madras BK,. 2006. (4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. J Med Chem 49: 1420-1432.
26. Morris K,. 2010. UK places generic ban on mephedrone drug family. Lancet 375 (9723): 1333-1334.
27. Newcombe R,. 2009. Mephedrone: Use of Mephedrone (M-Cat, Meow) in Middlesbrough. Lifeline: Manchester, UK.
28. Psychonaut Web Mapping Research Group. 2009. Mephedrone Report. Institute of Psychiatry: King's College London. Available at http://www.psychonautproject.eu/documents/reports/Mephedrone.pdf (Accessed 7 March 2014)
29. Psychonaut Web Mapping Research Project. 2010. Institute of Psychiatry: King's College London. Available at http://www.psychonautproject.eu/documents/reports/Psychonaut-Project-Executive-Summary.pdf (Accessed 7 March 2014)
30. Ricci V, Martinotti G, Gelfo F, et al,. 2011. Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. doi: 10.1007/s00213-010-2121-3.
31. Schifano F,. 2004. A bitter pill? Overview of ecstasy (MDMA; MDA) related fatalities. Psychopharmacology (Berl) (Berl) 173: 242-248.
32. Schifano F, Deluca P, Agosti L, et al,. 2005. New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic'). J Psychopharmacol 19 (6): 675-679.
33. Schifano F, Corkery J, Naidoo V, Oyefeso A, Ghodse H,. 2010. Overview of amphetamine-type stimulant mortality data-UK, 1997-2007. Neuropsychobiology 61: 122-130.
34. Schifano F, Albanese A, Fergus S, et al,. 2011. Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues. Psychopharmacology (Berl) 214: 593-602.
35. Schifano F, Corkery J, Ghodse AH,. 2012. Suspected and confirmed fatalities associated with mephedrone (4-methylmethcathinone, "meow meow") in the United Kingdom. J Clin Psychopharmacol 32: 710-714.
36. Simmler LD, Buser TA, Donzelli M, et al,. 2013. Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 168: 458-470.
37. Sumnall H, Wooding O,. 2009. Mephedrone: an update on current knowledge. Centre for Public Health: Liverpool John Moores University. Available at http://www.cph.org.uk/?s=mephedrone&post-type=publication (Accessed 7 March 2014)
38. Torrance H, Cooper G,. 2010. The detection of mephedrone (4-methyl-methcathinone) in 4 fatalities in Scotland. Forensic Sci Int 202: e62-e63.
39. Tsitsika A, Critselis E, Kormas G, et al,. 2009. Internet use and misuse: a multivariate regression analysis of the predictive factors of Internet use among Greek adolescents. Eur J Pediatr 168: 655-665.
40. United Nations Office on Drugs and Crime (UNODC). 2013. World Drug Report 2013. Available at: http://www.unodc.org/wdr/en/nps.html (Accessed 3 June 2014)
41. Winstock A,. 2013. Mixmag's global survey: the results. 264: 76-81. Available at http://www.mixmag.net/words/features/mixmags-global-drug-survey-the-results (Accessed 7 March 2014)
42. Winstock AR, Marsden J, Mitcheson L,. 2010a. What should be done about mephedrone? BMJ 340: c1605.
43. Winstock AR, Mitcheson L, Marsden J,. 2010b. Mephedrone: still available and twice the price. Lancet 376: 1537.
44. Winstock AR, Mitcheson L, Deluca P, Davey Z, Corazza O, Schifano F,. 2011. Mephedrone, new kid for the chop? Addiction 106: 154-161.
45. Wood DM, Davies S, Puchnarewicz M, et al,. 2010. Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J Med Toxicol 6: 327-330.
46. Wood DM, Hunter L, Measham F, Dargan PI,. 2012. Limited use of novel psychoactive substances in South London nightclubs. QJM 105: 959-964.
47. Wood DM, Greene SL, Dargan PI,. 2013. Emergency department presentations in determining the effectiveness of drug control in the United Kingdom: mephedrone (4-methylmethcathinone) control appears to be effective using this model. Emerg Med J 30: 70-71.
48. Wood DM, Hill SL, Thomas SH, Dargan PI,. Using poisons information service data to assess the acute harms associated with novel psychoactive substances. Drug Test Anal 2014. doi: 10.1002/dta.1671.
49. Yamamoto T, Kawsar A, Ramsey J, Dargan PI, Wood DM,. 2013. Monitoring trends in recreational drug use from the analysis of the contents of amnesty bins in gay dance clubs. QJM 106: 1111-1117.